Triethylamine → HCID 178491245, compound
Reaction equation
Cl[C:2]1[C:7]([F:8])=[CH:6][NH:5][C:4](=[O:9])[N:3]=1.C(N(CC)CC)C.O.[NH2:18][NH2:19].[CH3:20][O:21][C:22]1[CH:29]=[CH:28][C:25]([CH:26]=O)=[CH:24][CH:23]=1>C(O)C>[F:8][C:7]1[C:2]([NH:18]/[N:19]=[CH:26]/[C:25]2[CH:28]=[CH:29][C:22]([O:21][CH3:20])=[CH:23][CH:24]=2)=[N:3][C:4](=[O:9])[NH:5][CH:6]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A 25 mL vial was charged with 4-chloro-5-fluoropyrimidin-2(1H)-one (149 mg, 1.00 mmol),* ethanol (4 mL), triethylamine (148 μL, 1.06 mmol), and hydrazine monohydrate (52 μL, 1.07 mmol). The resulting yellow solution was agitated on an orbital shaker at room temperature for 3 h. 4-Methoxybenzaldehyde (123 μL, 1.01 mmol) was added, and the reaction mixture was heated at 50° C. for 16 h. After cooling to room temperature, the crude material was concentrated under reduced pressure and purified by reverse phase flash column chromatography to afford the title compound (49.3 mg, 19%) as a yellow solid: mp 202-208° C.; 1H NMR (300 MHz, DMSO-d6) δ 10.60 (bs, 1H), 10.14 (s, 1H), 8.35 (s, 1H), 7.97 (d, J=8.8 Hz, 2H), 7.38 (t, J=5.9 Hz, 1H), 6.97 (d, J=8.9 Hz, 2H), 3.80 (s, 3H); MS (ESI) ink 263 (M+H)+, 261 (M−H)−. *Driscoll, J. S.; Marquez, V. E.; Plowman, J.; Liu, P. S.; Kelley, J. A.; Barchi, J. J. J. Med. Chem. 1991, 34, 3280-3284. Yamashita, J.; Yamawaki, I; Ueda, S.; Yasumoto, M.; Unemi, N.; Hashimoto, S. Chem. Pharm. Bull. 1982, 30, 4258-4267.
Workup
- temperaturethe reaction mixture was heated at 50° C. for 16 h
- temperatureAfter cooling to room temperature
- concentrationthe crude material was concentrated under reduced pressure
- custompurified by reverse phase flash column chromatography
Sources & evidence
- ORD record
- ord-d986a3687fbd48caacc61c2213c10611
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09204653B2
Reaction notes
Loading…